Transforming growth factor beta receptor ligand trap

A transforming growth factor beta receptor ligand trap is an engineered biologic agent designed to bind and neutralize one or more isoforms of transforming growth factor beta (TGF-beta), thereby preventing their interaction with native cell-surface receptors. These traps typically consist of extracellular domains from one or more types of human TGF-beta receptors fused together—often linked to an immunoglobulin Fc region—to increase stability and half-life. By sequestering active cytokine before it can engage its serine/threonine kinase receptors on target cells, these agents aim to block pathological overactivation seen in diseases such as cancer and fibrosis while minimizing off-target effects compared with direct kinase inhibitors. However, because they broadly inhibit all biological activities mediated by the targeted ligands—including normal tissue repair and immune regulation—careful patient selection and monitoring are required during clinical development.

Other names

TGF-beta ligand trapTGF-beta decoy receptorSoluble TGF-beta receptor fusion proteinLigand trap for transforming growth factor beta

Sequestration of circulating transforming growth factor beta ligands, preventing them from binding to cell-surface receptors and activating downstream signaling pathways